medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2204232, encodeId=50e2220423253, content=偏重的研究方向：医学综合 经验分享：请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c7c8423369, createdName=ms6000000252792418, createdTime=Sun May 12 12:53:33 CST 2024, time=7小时前, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204231, encodeId=2e582204231d3, content=请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c7c8423369, createdName=ms6000000252792418, createdTime=Sun May 12 12:46:42 CST 2024, time=7小时前, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190169, encodeId=8fef2190169b0, content=请问大家revise以后都接收了吗？我已经修回16天了，还在with editor,也写信催过，说是会赶快给结果，然而并没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0e5616056, createdName=ms9000000472246077, createdTime=Thu Feb 29 19:17:27 CST 2024, time=2024-02-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201692, encodeId=bc072201692cf, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：一次不错的投稿经历，三个月见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=259b8165148, createdName=ms7000002146994216, createdTime=Sat May 04 11:59:50 CST 2024, time=2024-05-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2201599, encodeId=a383220159927, content=3.21告诉我修改，3.22修回后一直we，想问问大家都多久有变化的啊，等的好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16f69284607, createdName=ms1000002099627074, createdTime=Fri May 03 13:39:01 CST 2024, time=2024-05-03, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1240202, encodeId=7c1a124020238, content=偏重的研究方向：肿瘤 经验分享：返修时只有一位审稿人给出意见，请问各位有没有类似情况？给出修改指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e62e5505390, createdName=瑶瑶童, createdTime=Mon Aug 22 00:06:30 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201116, encodeId=dd0f2201116f1, content=问一下 2024年 medicine是预警期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d369118495, createdName=ms3000001783210361, createdTime=Mon Apr 29 19:14:48 CST 2024, time=2024-04-29, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2200491, encodeId=54472200491de, content=偏重的研究方向：Meta分析 经验分享：小修之后三周了还没消息，会不会凉了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fe9098340, createdName=ms3000000594665618, createdTime=Fri Apr 26 10:28:36 CST 2024, time=2024-04-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2200152, encodeId=b73b2200152a7, content=偏重的研究方向：肿瘤 经验分享：请问大家文章接收了以后，大概多久进行校稿，接收12天了还没收到校稿信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4ea71944270, createdName=一大口内涵, createdTime=Wed Apr 24 17:08:02 CST 2024, time=2024-04-24, status=1, ipAttribution=山东省)]

7小时前 ms6000000252792418 来自湖南省

偏重的研究方向：医学综合
经验分享：请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2204232, encodeId=50e2220423253, content=偏重的研究方向：医学综合 经验分享：请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c7c8423369, createdName=ms6000000252792418, createdTime=Sun May 12 12:53:33 CST 2024, time=7小时前, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204231, encodeId=2e582204231d3, content=请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c7c8423369, createdName=ms6000000252792418, createdTime=Sun May 12 12:46:42 CST 2024, time=7小时前, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190169, encodeId=8fef2190169b0, content=请问大家revise以后都接收了吗？我已经修回16天了，还在with editor,也写信催过，说是会赶快给结果，然而并没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0e5616056, createdName=ms9000000472246077, createdTime=Thu Feb 29 19:17:27 CST 2024, time=2024-02-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201692, encodeId=bc072201692cf, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：一次不错的投稿经历，三个月见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=259b8165148, createdName=ms7000002146994216, createdTime=Sat May 04 11:59:50 CST 2024, time=2024-05-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2201599, encodeId=a383220159927, content=3.21告诉我修改，3.22修回后一直we，想问问大家都多久有变化的啊，等的好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16f69284607, createdName=ms1000002099627074, createdTime=Fri May 03 13:39:01 CST 2024, time=2024-05-03, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1240202, encodeId=7c1a124020238, content=偏重的研究方向：肿瘤 经验分享：返修时只有一位审稿人给出意见，请问各位有没有类似情况？给出修改指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e62e5505390, createdName=瑶瑶童, createdTime=Mon Aug 22 00:06:30 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201116, encodeId=dd0f2201116f1, content=问一下 2024年 medicine是预警期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d369118495, createdName=ms3000001783210361, createdTime=Mon Apr 29 19:14:48 CST 2024, time=2024-04-29, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2200491, encodeId=54472200491de, content=偏重的研究方向：Meta分析 经验分享：小修之后三周了还没消息，会不会凉了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fe9098340, createdName=ms3000000594665618, createdTime=Fri Apr 26 10:28:36 CST 2024, time=2024-04-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2200152, encodeId=b73b2200152a7, content=偏重的研究方向：肿瘤 经验分享：请问大家文章接收了以后，大概多久进行校稿，接收12天了还没收到校稿信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4ea71944270, createdName=一大口内涵, createdTime=Wed Apr 24 17:08:02 CST 2024, time=2024-04-24, status=1, ipAttribution=山东省)]

7小时前 ms6000000252792418 来自湖南省

请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2204232, encodeId=50e2220423253, content=偏重的研究方向：医学综合 经验分享：请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c7c8423369, createdName=ms6000000252792418, createdTime=Sun May 12 12:53:33 CST 2024, time=7小时前, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204231, encodeId=2e582204231d3, content=请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c7c8423369, createdName=ms6000000252792418, createdTime=Sun May 12 12:46:42 CST 2024, time=7小时前, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190169, encodeId=8fef2190169b0, content=请问大家revise以后都接收了吗？我已经修回16天了，还在with editor,也写信催过，说是会赶快给结果，然而并没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0e5616056, createdName=ms9000000472246077, createdTime=Thu Feb 29 19:17:27 CST 2024, time=2024-02-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201692, encodeId=bc072201692cf, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：一次不错的投稿经历，三个月见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=259b8165148, createdName=ms7000002146994216, createdTime=Sat May 04 11:59:50 CST 2024, time=2024-05-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2201599, encodeId=a383220159927, content=3.21告诉我修改，3.22修回后一直we，想问问大家都多久有变化的啊，等的好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16f69284607, createdName=ms1000002099627074, createdTime=Fri May 03 13:39:01 CST 2024, time=2024-05-03, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1240202, encodeId=7c1a124020238, content=偏重的研究方向：肿瘤 经验分享：返修时只有一位审稿人给出意见，请问各位有没有类似情况？给出修改指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e62e5505390, createdName=瑶瑶童, createdTime=Mon Aug 22 00:06:30 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201116, encodeId=dd0f2201116f1, content=问一下 2024年 medicine是预警期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d369118495, createdName=ms3000001783210361, createdTime=Mon Apr 29 19:14:48 CST 2024, time=2024-04-29, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2200491, encodeId=54472200491de, content=偏重的研究方向：Meta分析 经验分享：小修之后三周了还没消息，会不会凉了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fe9098340, createdName=ms3000000594665618, createdTime=Fri Apr 26 10:28:36 CST 2024, time=2024-04-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2200152, encodeId=b73b2200152a7, content=偏重的研究方向：肿瘤 经验分享：请问大家文章接收了以后，大概多久进行校稿，接收12天了还没收到校稿信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4ea71944270, createdName=一大口内涵, createdTime=Wed Apr 24 17:08:02 CST 2024, time=2024-04-24, status=1, ipAttribution=山东省)]

2024-02-29 ms9000000472246077 来自山东省

请问大家revise以后都接收了吗？我已经修回16天了，还在with editor,也写信催过，说是会赶快给结果，然而并没有

19 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204232, encodeId=50e2220423253, content=偏重的研究方向：医学综合 经验分享：请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c7c8423369, createdName=ms6000000252792418, createdTime=Sun May 12 12:53:33 CST 2024, time=7小时前, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204231, encodeId=2e582204231d3, content=请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c7c8423369, createdName=ms6000000252792418, createdTime=Sun May 12 12:46:42 CST 2024, time=7小时前, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190169, encodeId=8fef2190169b0, content=请问大家revise以后都接收了吗？我已经修回16天了，还在with editor,也写信催过，说是会赶快给结果，然而并没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0e5616056, createdName=ms9000000472246077, createdTime=Thu Feb 29 19:17:27 CST 2024, time=2024-02-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201692, encodeId=bc072201692cf, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：一次不错的投稿经历，三个月见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=259b8165148, createdName=ms7000002146994216, createdTime=Sat May 04 11:59:50 CST 2024, time=2024-05-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2201599, encodeId=a383220159927, content=3.21告诉我修改，3.22修回后一直we，想问问大家都多久有变化的啊，等的好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16f69284607, createdName=ms1000002099627074, createdTime=Fri May 03 13:39:01 CST 2024, time=2024-05-03, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1240202, encodeId=7c1a124020238, content=偏重的研究方向：肿瘤 经验分享：返修时只有一位审稿人给出意见，请问各位有没有类似情况？给出修改指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e62e5505390, createdName=瑶瑶童, createdTime=Mon Aug 22 00:06:30 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201116, encodeId=dd0f2201116f1, content=问一下 2024年 medicine是预警期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d369118495, createdName=ms3000001783210361, createdTime=Mon Apr 29 19:14:48 CST 2024, time=2024-04-29, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2200491, encodeId=54472200491de, content=偏重的研究方向：Meta分析 经验分享：小修之后三周了还没消息，会不会凉了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fe9098340, createdName=ms3000000594665618, createdTime=Fri Apr 26 10:28:36 CST 2024, time=2024-04-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2200152, encodeId=b73b2200152a7, content=偏重的研究方向：肿瘤 经验分享：请问大家文章接收了以后，大概多久进行校稿，接收12天了还没收到校稿信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4ea71944270, createdName=一大口内涵, createdTime=Wed Apr 24 17:08:02 CST 2024, time=2024-04-24, status=1, ipAttribution=山东省)]

2024-03-25 X.Dawn 来自浙江省

medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了

18 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204232, encodeId=50e2220423253, content=偏重的研究方向：医学综合 经验分享：请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c7c8423369, createdName=ms6000000252792418, createdTime=Sun May 12 12:53:33 CST 2024, time=7小时前, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204231, encodeId=2e582204231d3, content=请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c7c8423369, createdName=ms6000000252792418, createdTime=Sun May 12 12:46:42 CST 2024, time=7小时前, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190169, encodeId=8fef2190169b0, content=请问大家revise以后都接收了吗？我已经修回16天了，还在with editor,也写信催过，说是会赶快给结果，然而并没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0e5616056, createdName=ms9000000472246077, createdTime=Thu Feb 29 19:17:27 CST 2024, time=2024-02-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201692, encodeId=bc072201692cf, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：一次不错的投稿经历，三个月见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=259b8165148, createdName=ms7000002146994216, createdTime=Sat May 04 11:59:50 CST 2024, time=2024-05-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2201599, encodeId=a383220159927, content=3.21告诉我修改，3.22修回后一直we，想问问大家都多久有变化的啊，等的好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16f69284607, createdName=ms1000002099627074, createdTime=Fri May 03 13:39:01 CST 2024, time=2024-05-03, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1240202, encodeId=7c1a124020238, content=偏重的研究方向：肿瘤 经验分享：返修时只有一位审稿人给出意见，请问各位有没有类似情况？给出修改指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e62e5505390, createdName=瑶瑶童, createdTime=Mon Aug 22 00:06:30 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201116, encodeId=dd0f2201116f1, content=问一下 2024年 medicine是预警期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d369118495, createdName=ms3000001783210361, createdTime=Mon Apr 29 19:14:48 CST 2024, time=2024-04-29, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2200491, encodeId=54472200491de, content=偏重的研究方向：Meta分析 经验分享：小修之后三周了还没消息，会不会凉了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fe9098340, createdName=ms3000000594665618, createdTime=Fri Apr 26 10:28:36 CST 2024, time=2024-04-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2200152, encodeId=b73b2200152a7, content=偏重的研究方向：肿瘤 经验分享：请问大家文章接收了以后，大概多久进行校稿，接收12天了还没收到校稿信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4ea71944270, createdName=一大口内涵, createdTime=Wed Apr 24 17:08:02 CST 2024, time=2024-04-24, status=1, ipAttribution=山东省)]

2024-05-04 ms7000002146994216 来自湖北省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：药理
经验分享：一次不错的投稿经历，三个月见刊。

12 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204232, encodeId=50e2220423253, content=偏重的研究方向：医学综合 经验分享：请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c7c8423369, createdName=ms6000000252792418, createdTime=Sun May 12 12:53:33 CST 2024, time=7小时前, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204231, encodeId=2e582204231d3, content=请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c7c8423369, createdName=ms6000000252792418, createdTime=Sun May 12 12:46:42 CST 2024, time=7小时前, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190169, encodeId=8fef2190169b0, content=请问大家revise以后都接收了吗？我已经修回16天了，还在with editor,也写信催过，说是会赶快给结果，然而并没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0e5616056, createdName=ms9000000472246077, createdTime=Thu Feb 29 19:17:27 CST 2024, time=2024-02-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201692, encodeId=bc072201692cf, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：一次不错的投稿经历，三个月见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=259b8165148, createdName=ms7000002146994216, createdTime=Sat May 04 11:59:50 CST 2024, time=2024-05-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2201599, encodeId=a383220159927, content=3.21告诉我修改，3.22修回后一直we，想问问大家都多久有变化的啊，等的好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16f69284607, createdName=ms1000002099627074, createdTime=Fri May 03 13:39:01 CST 2024, time=2024-05-03, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1240202, encodeId=7c1a124020238, content=偏重的研究方向：肿瘤 经验分享：返修时只有一位审稿人给出意见，请问各位有没有类似情况？给出修改指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e62e5505390, createdName=瑶瑶童, createdTime=Mon Aug 22 00:06:30 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201116, encodeId=dd0f2201116f1, content=问一下 2024年 medicine是预警期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d369118495, createdName=ms3000001783210361, createdTime=Mon Apr 29 19:14:48 CST 2024, time=2024-04-29, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2200491, encodeId=54472200491de, content=偏重的研究方向：Meta分析 经验分享：小修之后三周了还没消息，会不会凉了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fe9098340, createdName=ms3000000594665618, createdTime=Fri Apr 26 10:28:36 CST 2024, time=2024-04-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2200152, encodeId=b73b2200152a7, content=偏重的研究方向：肿瘤 经验分享：请问大家文章接收了以后，大概多久进行校稿，接收12天了还没收到校稿信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4ea71944270, createdName=一大口内涵, createdTime=Wed Apr 24 17:08:02 CST 2024, time=2024-04-24, status=1, ipAttribution=山东省)]

2024-05-03 ms1000002099627074 来自吉林省

3.21告诉我修改，3.22修回后一直we，想问问大家都多久有变化的啊，等的好着急

9 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204232, encodeId=50e2220423253, content=偏重的研究方向：医学综合 经验分享：请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c7c8423369, createdName=ms6000000252792418, createdTime=Sun May 12 12:53:33 CST 2024, time=7小时前, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204231, encodeId=2e582204231d3, content=请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c7c8423369, createdName=ms6000000252792418, createdTime=Sun May 12 12:46:42 CST 2024, time=7小时前, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190169, encodeId=8fef2190169b0, content=请问大家revise以后都接收了吗？我已经修回16天了，还在with editor,也写信催过，说是会赶快给结果，然而并没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0e5616056, createdName=ms9000000472246077, createdTime=Thu Feb 29 19:17:27 CST 2024, time=2024-02-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201692, encodeId=bc072201692cf, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：一次不错的投稿经历，三个月见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=259b8165148, createdName=ms7000002146994216, createdTime=Sat May 04 11:59:50 CST 2024, time=2024-05-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2201599, encodeId=a383220159927, content=3.21告诉我修改，3.22修回后一直we，想问问大家都多久有变化的啊，等的好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16f69284607, createdName=ms1000002099627074, createdTime=Fri May 03 13:39:01 CST 2024, time=2024-05-03, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1240202, encodeId=7c1a124020238, content=偏重的研究方向：肿瘤 经验分享：返修时只有一位审稿人给出意见，请问各位有没有类似情况？给出修改指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e62e5505390, createdName=瑶瑶童, createdTime=Mon Aug 22 00:06:30 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201116, encodeId=dd0f2201116f1, content=问一下 2024年 medicine是预警期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d369118495, createdName=ms3000001783210361, createdTime=Mon Apr 29 19:14:48 CST 2024, time=2024-04-29, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2200491, encodeId=54472200491de, content=偏重的研究方向：Meta分析 经验分享：小修之后三周了还没消息，会不会凉了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fe9098340, createdName=ms3000000594665618, createdTime=Fri Apr 26 10:28:36 CST 2024, time=2024-04-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2200152, encodeId=b73b2200152a7, content=偏重的研究方向：肿瘤 经验分享：请问大家文章接收了以后，大概多久进行校稿，接收12天了还没收到校稿信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4ea71944270, createdName=一大口内涵, createdTime=Wed Apr 24 17:08:02 CST 2024, time=2024-04-24, status=1, ipAttribution=山东省)]

2022-08-22 瑶瑶童

偏重的研究方向：肿瘤
经验分享：返修时只有一位审稿人给出意见，请问各位有没有类似情况？给出修改指导

60 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204232, encodeId=50e2220423253, content=偏重的研究方向：医学综合 经验分享：请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c7c8423369, createdName=ms6000000252792418, createdTime=Sun May 12 12:53:33 CST 2024, time=7小时前, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204231, encodeId=2e582204231d3, content=请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c7c8423369, createdName=ms6000000252792418, createdTime=Sun May 12 12:46:42 CST 2024, time=7小时前, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190169, encodeId=8fef2190169b0, content=请问大家revise以后都接收了吗？我已经修回16天了，还在with editor,也写信催过，说是会赶快给结果，然而并没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0e5616056, createdName=ms9000000472246077, createdTime=Thu Feb 29 19:17:27 CST 2024, time=2024-02-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201692, encodeId=bc072201692cf, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：一次不错的投稿经历，三个月见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=259b8165148, createdName=ms7000002146994216, createdTime=Sat May 04 11:59:50 CST 2024, time=2024-05-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2201599, encodeId=a383220159927, content=3.21告诉我修改，3.22修回后一直we，想问问大家都多久有变化的啊，等的好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16f69284607, createdName=ms1000002099627074, createdTime=Fri May 03 13:39:01 CST 2024, time=2024-05-03, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1240202, encodeId=7c1a124020238, content=偏重的研究方向：肿瘤 经验分享：返修时只有一位审稿人给出意见，请问各位有没有类似情况？给出修改指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e62e5505390, createdName=瑶瑶童, createdTime=Mon Aug 22 00:06:30 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201116, encodeId=dd0f2201116f1, content=问一下 2024年 medicine是预警期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d369118495, createdName=ms3000001783210361, createdTime=Mon Apr 29 19:14:48 CST 2024, time=2024-04-29, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2200491, encodeId=54472200491de, content=偏重的研究方向：Meta分析 经验分享：小修之后三周了还没消息，会不会凉了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fe9098340, createdName=ms3000000594665618, createdTime=Fri Apr 26 10:28:36 CST 2024, time=2024-04-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2200152, encodeId=b73b2200152a7, content=偏重的研究方向：肿瘤 经验分享：请问大家文章接收了以后，大概多久进行校稿，接收12天了还没收到校稿信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4ea71944270, createdName=一大口内涵, createdTime=Wed Apr 24 17:08:02 CST 2024, time=2024-04-24, status=1, ipAttribution=山东省)]

2024-04-29 ms3000001783210361 来自福建省

问一下 2024年 medicine是预警期刊吗

7 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204232, encodeId=50e2220423253, content=偏重的研究方向：医学综合 经验分享：请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c7c8423369, createdName=ms6000000252792418, createdTime=Sun May 12 12:53:33 CST 2024, time=7小时前, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204231, encodeId=2e582204231d3, content=请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c7c8423369, createdName=ms6000000252792418, createdTime=Sun May 12 12:46:42 CST 2024, time=7小时前, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190169, encodeId=8fef2190169b0, content=请问大家revise以后都接收了吗？我已经修回16天了，还在with editor,也写信催过，说是会赶快给结果，然而并没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0e5616056, createdName=ms9000000472246077, createdTime=Thu Feb 29 19:17:27 CST 2024, time=2024-02-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201692, encodeId=bc072201692cf, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：一次不错的投稿经历，三个月见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=259b8165148, createdName=ms7000002146994216, createdTime=Sat May 04 11:59:50 CST 2024, time=2024-05-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2201599, encodeId=a383220159927, content=3.21告诉我修改，3.22修回后一直we，想问问大家都多久有变化的啊，等的好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16f69284607, createdName=ms1000002099627074, createdTime=Fri May 03 13:39:01 CST 2024, time=2024-05-03, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1240202, encodeId=7c1a124020238, content=偏重的研究方向：肿瘤 经验分享：返修时只有一位审稿人给出意见，请问各位有没有类似情况？给出修改指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e62e5505390, createdName=瑶瑶童, createdTime=Mon Aug 22 00:06:30 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201116, encodeId=dd0f2201116f1, content=问一下 2024年 medicine是预警期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d369118495, createdName=ms3000001783210361, createdTime=Mon Apr 29 19:14:48 CST 2024, time=2024-04-29, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2200491, encodeId=54472200491de, content=偏重的研究方向：Meta分析 经验分享：小修之后三周了还没消息，会不会凉了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fe9098340, createdName=ms3000000594665618, createdTime=Fri Apr 26 10:28:36 CST 2024, time=2024-04-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2200152, encodeId=b73b2200152a7, content=偏重的研究方向：肿瘤 经验分享：请问大家文章接收了以后，大概多久进行校稿，接收12天了还没收到校稿信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4ea71944270, createdName=一大口内涵, createdTime=Wed Apr 24 17:08:02 CST 2024, time=2024-04-24, status=1, ipAttribution=山东省)]

2024-04-26 ms3000000594665618 来自四川省

偏重的研究方向：Meta分析
经验分享：小修之后三周了还没消息，会不会凉了？

13 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204232, encodeId=50e2220423253, content=偏重的研究方向：医学综合 经验分享：请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c7c8423369, createdName=ms6000000252792418, createdTime=Sun May 12 12:53:33 CST 2024, time=7小时前, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204231, encodeId=2e582204231d3, content=请问各位大佬，一审RRC一周后UR是什么情况？已经UR三个月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c7c8423369, createdName=ms6000000252792418, createdTime=Sun May 12 12:46:42 CST 2024, time=7小时前, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190169, encodeId=8fef2190169b0, content=请问大家revise以后都接收了吗？我已经修回16天了，还在with editor,也写信催过，说是会赶快给结果，然而并没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0e5616056, createdName=ms9000000472246077, createdTime=Thu Feb 29 19:17:27 CST 2024, time=2024-02-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201692, encodeId=bc072201692cf, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：一次不错的投稿经历，三个月见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=259b8165148, createdName=ms7000002146994216, createdTime=Sat May 04 11:59:50 CST 2024, time=2024-05-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2201599, encodeId=a383220159927, content=3.21告诉我修改，3.22修回后一直we，想问问大家都多久有变化的啊，等的好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16f69284607, createdName=ms1000002099627074, createdTime=Fri May 03 13:39:01 CST 2024, time=2024-05-03, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1240202, encodeId=7c1a124020238, content=偏重的研究方向：肿瘤 经验分享：返修时只有一位审稿人给出意见，请问各位有没有类似情况？给出修改指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e62e5505390, createdName=瑶瑶童, createdTime=Mon Aug 22 00:06:30 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201116, encodeId=dd0f2201116f1, content=问一下 2024年 medicine是预警期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d369118495, createdName=ms3000001783210361, createdTime=Mon Apr 29 19:14:48 CST 2024, time=2024-04-29, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2200491, encodeId=54472200491de, content=偏重的研究方向：Meta分析 经验分享：小修之后三周了还没消息，会不会凉了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fe9098340, createdName=ms3000000594665618, createdTime=Fri Apr 26 10:28:36 CST 2024, time=2024-04-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2200152, encodeId=b73b2200152a7, content=偏重的研究方向：肿瘤 经验分享：请问大家文章接收了以后，大概多久进行校稿，接收12天了还没收到校稿信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4ea71944270, createdName=一大口内涵, createdTime=Wed Apr 24 17:08:02 CST 2024, time=2024-04-24, status=1, ipAttribution=山东省)]

2024-04-24 一大口内涵来自山东省

偏重的研究方向：肿瘤
经验分享：请问大家文章接收了以后，大概多久进行校稿，接收12天了还没收到校稿信息

14 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务